FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arthur Sagalowsky

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Biological Tumor Markers

Co-author Network

Publications

TOP 3
Aditya Bagrodia; Karim Bensalah; Ithaar H Derweesh; Bishoy A Gayed; Payal Kapur; Franklin E Kuehhas; Yair Lotan; Jay D Raman; Arthur I Sagalowsky; Shahrokh F Shariat; Christopher G Wood; Vitaly Margulis
Comparative Analysis of Oncologic Outcomes of Partial Ureterectomy vs Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
Wassim Kassouf; Seth P Lerner; Yair Lotan; Giacomo Novara; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat; Armen Aprikian; Patrick J Bastian; Colin P N Dinney; Vincenzo Ficarra; Yves Fradet; Hans Martin Fritsche; Jonathan I Izawa; Ashish M Kamat; Pierre I Karakiewicz; Robert S Svatek; Derya Tilki; Eila C Skinner
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Arthur I Sagalowsky
Words of Wisdom: re: a systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arthur Sagalowsky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Aditya Bagrodia; Karim Bensalah; Ithaar H Derweesh; Bishoy A Gayed; Payal Kapur; Franklin E Kuehhas; Yair Lotan; Jay D Raman; Arthur I Sagalowsky; Shahrokh F Shariat; Christopher G Wood; Vitaly Margulis
Comparative Analysis of Oncologic Outcomes of Partial Ureterectomy vs Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
Urology 2013;81(5):972-8.
2013: Wassim Kassouf; Seth P Lerner; Yair Lotan; Giacomo Novara; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat; Armen Aprikian; Patrick J Bastian; Colin P N Dinney; Vincenzo Ficarra; Yves Fradet; Hans Martin Fritsche; Jonathan I Izawa; Ashish M Kamat; Pierre I Karakiewicz; Robert S Svatek; Derya Tilki; Eila C Skinner
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Urologic oncology 2013;31(4):480-6.
2013: Arthur I Sagalowsky
Words of Wisdom: re: a systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
European urology 2013;63(3):579-80.
2013: Oussama M Darwish; Payal Kapur; Yair Lotan; Feras Alhalabi; Aditya Bagrodia; Michael Belsante; Arthur I Sagalowsky; Ramy F Youssef; Vitaly Margulis
Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
Urology 2013;81(3):581-6.
2012: Mehrad Adibi; Christian Bolenz; Yair Lotan; Francesco Montorsi; Arthur I Sagalowsky; Shahrokh F Shariat; Christopher G Wood; Ramy Youssef; Richard Zigeuner; Vitaly Margulis
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.
International journal of urology : official journal of the Japanese Urological Association 2012;19(12):1060-6.
2012: Nicholas G Cost; Patricio C Gargollo; Candace F Granberg; Jessica D Lubahn; Vitaly Margulis; Arthur I Sagalowsky; Jonathan E Wickiser; Linda A Baker; Dinesh Rakheja
Pathological review of Wilms tumor nephrectomy specimens and potential implications for nephron sparing surgery in Wilms tumor.
The Journal of urology 2012;188(4 Suppl):1506-10.
2012: Nicholas G Cost; Jessica D Lubahn; Ganesh V Raj; Adam Romman; Arthur I Sagalowsky; Mehrad Adibi; Vitaly Margulis
Effect of testicular germ cell tumor therapy on renal function.
Urology 2012;80(3):641-8.
2012: Samuel Peña-Llopis; Mark T Ross; Arthur I Sagalowsky; Sharanya Sivanand; Patrick Spence; Pia Banerji Summerour; Silvia Vega-Rubín-de-Celis; Shanshan Wang; S W Wendy Wong; Xian-Jin Xie; Toshinari Yamasaki; Leah Zhrebker; Nick Grishin; Tina Hambuch; Christian D Haudenschild; Suneer Jain; Wareef Kabbani; Payal Kapur; Lisa Kinch; Marc Laurent; Nan Leng; Arnold Liao; Yair Lotan; Vitaly Margulis; Andrea Pavía-Jiménez; David R Bentley; James Brugarolas
BAP1 loss defines a new class of renal cell carcinoma.
Nature genetics 2012;44(7):751-9.
2012: Arthur I Sagalowsky
Editorial comment.
The Journal of urology 2012;188(1):62.
2012: Aditya Bagrodia; Michael J Belsante; Chase Cannon; Oussama M Darwish; Deniz Gerecci; Payal Kapur; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat; Ramy F Youssef; Vitaly Margulis
Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
European urology 2012;62(1):e27-9.
2012: Ramy F Youssef; Raheela Ashfaq; Richard Ho; Arthur I Sagalowsky; Bruce J Schlomer; Yair Lotan
Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology.
Urologic oncology 2012;30(3):273-7.
2012: Michael Rink; Brian D Robinson; Arthur I Sagalowsky; Douglas S Scherr; Eugene K Cha; Felix K Chun; Margit Fisch; David Green; Jens Hansen; Pierre I Karakiewicz; Yair Lotan; Shahrokh F Shariat
Biomolecular predictors of urothelial cancer behavior and treatment outcomes.
Current urology reports 2012;13(2):122-35.
2011: Jay D Raman; Mesut Remzi; Marco Roscigno; Arthur I Sagalowsky; Douglas S Scherr; Shahrokh F Shariat; Matthias Waldert; Alon Z Weizer; Jeffery C Wheat; Christopher G Wood; Christian Bolenz; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Casey K Ng
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Urologic oncology 2011;29(6):716-23.
2011: Ramy F Youssef; Richard Zigeuner; Christian Bolenz; Charles C Guo; Wareef Kabbani; Wassim Kassouf; Eiji Kikuchi; Cord Langner; Yair Lotan; Francesco Montorsi; Jay D Raman; Mesut Remzi; Marco Roscigno; Arthur I Sagalowsky; Shahrokh F Shariat; Alon Z Weizer; Christopher G Wood; Vitaly Margulis
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
BJU international 2011;108(8):1286-91.
2011: Jose A Karam; Sandra Huang; Jinhai Fan; Jennifer Stanfield; Roger A Schultz; Rey-Chen Pong; Xiankai Sun; Ralph P Mason; Xian-Jin Xie; Gang Niu; Xiaoyuan Chen; Eugene P Frenkel; Arthur I Sagalowsky; Jer-Tsong Hsieh
Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.
International journal of cancer. Journal international du cancer 2011;128(12):2823-32.
2011: Nicholas G Cost; Scott E Delacroix; Joshua P Sleeper; Paul J Smith; Ramy F Youssef; Brian F Chapin; Jose A Karam; Stephen Culp; E Jason Abel; James Brugarolas; Ganesh V Raj; Arthur I Sagalowsky; Christopher G Wood; Vitaly Margulis
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
European urology 2011;59(6):912-8.
2011: Cenk Gurbuz; Ramy F Youssef; Shahrokh F Shariat; Yair Lotan; Christopher G Wood; Arthur I Sagalowsky; Richard Zigeuner; Eiji Kikuchi; Alon Z Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Vitaly Margulis
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Journal of endourology / Endourological Society 2011;25(5):775-9.
2011: Arthur I Sagalowsky
Editorial comment.
Urology 2011;77(4):859; author reply 859-60.
2011: Arthur I Sagalowsky
Treatment options for patients with stage I nonseminomatous testis cancer: it's all good.
European urology 2011;59(4):563-5.
2011: Ramy F Youssef; Shahrokh F Shariat; Yair Lotan; Christopher G Wood; Arthur I Sagalowsky; Richard Zigeuner; Cord Langner; Francesco Montorsi; Christian Bolenz; Vitaly Margulis
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.
Urology 2011;77(4):861-6.
2011: Guru Sonpavde; Myrna M Khan; Seth P Lerner; Robert S Svatek; Giacomo Novara; Pierre I Karakiewicz; Eila Skinner; Derya Tilki; Wassim Kassouf; Yves Fradet; Colin P Dinney; Hans-Martin Fritsche; Jonathan I Izawa; Patrick J Bastian; Vincenzo Ficarra; Mark P Schoenberg; Arthur I Sagalowsky; Yair Lotan; Shahrokh F Shariat
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
The Journal of urology 2011;185(2):456-61.
2011: Ganesh V Raj; Saumil Karavadia; Bruce Schlomer; Yull Arriaga; Yair Lotan; Arthur I Sagalowsky; Eugene Frenkel
Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.
Cancer 2011;117(2):276-82.
2011: Vitaly Margulis; Arthur I Sagalowsky
Assessment of hematuria.
The Medical clinics of North America 2011;95(1):153-9.
2010: Christian Bolenz; Richard Ho; Geoffrey R Nuss; Nicolas Ortiz; Ganesh V Raj; Arthur I Sagalowsky; Yair Lotan
Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival.
BJU international 2010;106(9):1324-9.
2010: Christian Bolenz; Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Richard Ho; Arthur I Sagalowsky; Yair Lotan
Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder.
BJU international 2010;106(8):1216-22.
2010: Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene Siefker-Radtke; Randall E Millikan; Colin P N Dinney
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4461-7.
2010: Derya Tilki; Robert S Svatek; Giacomo Novara; Michael Seitz; Guilherme Godoy; Pierre I Karakiewicz; Wassim Kassouf; Yves Fradet; Hans-Martin Fritsche; Guru Sonpavde; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Oliver Reich; Shahrokh F Shariat
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
The Journal of urology 2010;184(3):888-94.
2010: Vitaly Margulis; Arthur I Sagalowsky
Penile cancer: management of regional lymphatic drainage.
The Urologic clinics of North America 2010;37(3):411-9.
2010: Arthur I Sagalowsky
Editorial comment.
The Journal of urology 2010;184(2):480-1.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Giacomo Novara; Michael Seitz; Guru Sonpavde; Amit Gupta; Wassim Kassouf; Yves Fradet; Vincenzo Ficarra; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Christian G Stief; Oliver Reich; Shahrokh F Shariat
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
The Journal of urology 2010;184(2):470-4.
2010: Derya Tilki; Oliver Reich; Pierre I Karakiewicz; Giacomo Novara; Wassim Kassouf; Süleyman Ergün; Yves Fradet; Vincenzo Ficarra; Guru Sonpavde; Christian G Stief; Eila Skinner; Robert S Svatek; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
European urology 2010;58(1):112-7.
2010: Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Vincenzo Ficarra; Yves Fradet; Yair Lotan; Hendrik Isbarn; Umberto Capitanio; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Colin P Dinney; Seth P Lerner; Mark P Schoenberg; Bjoern G Volkmer; Arthur I Sagalowsky; Shahrokh F Shariat
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
The Journal of urology 2010;183(6):2165-70.
2010: Derya Tilki; Oliver Reich; Robert S Svatek; Pierre I Karakiewicz; Wassim Kassouf; Giacomo Novara; Vincenzo Ficarra; Daher C Chade; Hans-Martin Fritsche; Niklas Gerwens; Jonathan I Izawa; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
The Journal of urology 2010;183(5):1757-63.
2010: Shahrokh F Shariat; Ramy F Youssef; Amit Gupta; Daher C Chade; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Arthur I Sagalowsky; Raheela Ashfaq; Yair Lotan
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
The Journal of urology 2010;183(5):1744-50.
2010: Shahrokh F Shariat; Robert S Svatek; Derya Tilki; Eila Skinner; Pierre I Karakiewicz; Umberto Capitanio; Patrick J Bastian; Bjoern G Volkmer; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish M Kamat; Colin P Dinney; Yair Lotan; Michael J Marberger; Yves Fradet
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
BJU international 2010;105(10):1402-12.
2010: Glenn N Levine; Anthony V D'Amico; Peter Berger; Peter E Clark; Robert H Eckel; Nancy L Keating; Richard V Milani; Arthur I Sagalowsky; Matthew R Smith; Neil Zakai
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
CA: a cancer journal for clinicians 2010;60(3):194-201.
2010: Arthur I Sagalowsky
Editorial comment.
The Journal of urology 2010;183(4):1341-2.
2010: Arthur I Sagalowsky
Editorial comment.
The Journal of urology 2010;183(3):928.
2010: Glenn N Levine; Anthony V D'Amico; Peter Berger; Peter E Clark; Robert H Eckel; Nancy L Keating; Richard V Milani; Arthur I Sagalowsky; Matthew R Smith; Neil Zakai
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
Circulation 2010;121(6):833-40.
2010: Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
European urology 2010;57(2):300-9.
2010: Shahrokh F Shariat; Christian Bolenz; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Jérôme Rigaud; Stefan C Müller; Seth P Lerner; Francesco Montorsi; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
BJU international 2010;105(4):489-95.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
The Journal of urology 2010;183(1):87-93.
2010: Bruce J Schlomer; Richard Ho; Arthur I Sagalowsky; Raheela Ashfaq; Yair Lotan
Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
The Journal of urology 2010;183(1):62-7.
2010: Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
The Journal of urology 2010;183(1):68-75.
2009: Shahrokh F Shariat; Pierre I Karakiewicz; Guilherme Godoy; Jose A Karam; Raheela Ashfaq; Yves Fradet; Hendrik Isbarn; Francesco Montorsi; Claudio Jeldres; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Arthur I Sagalowsky; Yair Lotan
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7012-9.
2009: Arthur I Sagalowsky
Editorial comment.
The Journal of urology 2009;182(4):1487.
2009: Jay D Raman; Karim Bensalah; Aditya Bagrodia; Chad R Tracy; Wareef Kabbani; Arthur I Sagalowsky; Jeffrey A Cadeddu
Comparison of tissue oxygenation profiles using 3 different methods of vascular control during porcine partial nephrectomy.
Urology 2009;74(4):926-31.
2009: Shahrokh F Shariat; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Stefan C Müller; Jose A Karam; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
The Journal of urology 2009;182(3):907-13.
2009: Hendrik Isbarn; Pierre I Karakiewicz; Shahrokh F Shariat; umberto capitanio; Ganesh S Palapattu; Arthur I Sagalowsky; Yair Lotan; Mark P Schoenberg; Gilad E Amiel; Seth P Lerner; Guru Sonpavde
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
The Journal of urology 2009;182(2):459-65; discussion 465.
2009: Aditya Bagrodia; Sonal Grover; Srivastava Abhishek; Amit Gupta; Christian Bolenz; Arthur I Sagalowsky; Yair Lotan
Impact of body mass index on clinical and cost outcomes after radical cystectomy.
BJU international 2009;104(3):326-30.
2009: Yair Lotan; Keren Elias; Robert S Svatek; Aditya Bagrodia; Geoffrey Nuss; Brett Moran; Arthur I Sagalowsky
Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
The Journal of urology 2009;182(1):52-7; discussion 58.
2009: Shahrokh F Shariat; Christian Bolenz; Guilherme Godoy; Yves Fradet; Raheela Ashfaq; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Jérôme Rigaud; Arthur I Sagalowsky; Yair Lotan
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
The Journal of urology 2009;182(1):78-84; discussion 84.
2009: umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Yair Lotan; Ganesh S Palapattu; Patrick J Bastian; Amit Gupta; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Pierre I Karakiewicz
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
BJU international 2009;103(10):1359-62.
2009: Vitaly Margulis; Yair Lotan; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Umberto Capitanio; Francesco Montorsi; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Jérôme Rigaud; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Journal of the National Cancer Institute 2009;101(2):114-9.
2008: Steven M Lucas; Geoffrey Nuss; Joshua Stern; Yair Lotan; Arthur I Sagalowsky; Jeffrey A Cadeddu; Ganesh V Raj
The screening for Occult Renal Disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small, unilateral renal masses.
Cancer 2008;113(10):2681-6.
2008: Arthur I Sagalowsky
Editorial comment on: significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
European urology 2008;54(5):1134-5.
2008: Steven M Lucas; Robert S Svatek; Guadencio Olgin; Yull Arriaga; Wareef Kabbani; Arthur I Sagalowsky; Yair Lotan
Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
BJU international 2008;102(2):172-6.
2008: Jochen Walz; Shahrokh F Shariat; Nazareno Suardi; Paul Perrotte; Yair Lotan; Ganesh S Palapattu; Amit Gupta; Patrick J Bastian; Craig G Rogers; Amnon Vazina; Gilad E Amiel; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner; Pierre I Karakiewicz
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Yair Lotan; Karim Bensalah; Timothy Ruddell; Shahrokh F Shariat; Arthur I Sagalowsky; Raheela Ashfaq
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
The Journal of urology 2008;179(6):2164-9.
2008: Jose A Karam; Wareef Kabbani; Arthur I Sagalowsky
Pseudosarcomatous fibromyxoid tumor of the bladder.
Urologic oncology 2008;26(3):291-4.
2008: Arthur I Sagalowsky
Commentary on clinical outcomes of sexuality preserving cystectomy and neobladder.
The Journal of urology 2008;179(5 Suppl):S39.
2008: Jose A Karam; Arthur I Sagalowsky
Minimally invasive radical cystectomy for bladder cancer?
The lancet oncology 2008;9(4):317-8.
2008: Arthur I Sagalowsky
Words of wisdom. Re: Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
European urology 2008;53(3):665-6.
2008: Georg C Hutterer; Pierre I Karakiewicz; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Paul Perrotte; Yair Lotan; Michael J Marberger; Shahrokh F Shariat
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU international 2008;101(5):561-5.
2008: Amit Gupta; Yair Lotan; Patrick J Bastian; Ganesh S Palapattu; Pierre I Karakiewicz; Ganesh V Raj; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Urology 2008;71(2):302-7.
2008: Patrick J Bastian; Georg C Hutterer; Shahrokh F Shariat; Craig G Rogers; Ganesh S Palapattu; Yair Lotan; Amnon Vazina; Gilad E Amiel; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg; Pierre I Karakiewicz
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU international 2008;101(4):450-4.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Seth P Lerner; Ganesh S Palapattu; Richard J Cote; Arthur I Sagalowsky; Yair Lotan
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
Cancer 2008;112(2):315-25.
2007: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Urologic oncology 2007;25(6):468-75.
2007: Matthew Nielsen; Ganesh S Palapattu; Pierre I Karakiewicz; Yair Lotan; Patrick J Bastian; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
BJU international 2007;100(5):1015-20.
2007: Arthur I Sagalowsky
Editorial Comment on: Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
European urology 2007;52(4):1162-3.
2007: Jose A Karam; Yair Lotan; Raheela Ashfaq; Arthur I Sagalowsky; Shahrokh F Shariat
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Urology 2007;70(3):482-6.
2007: Jose A Karam; Shahrokh F Shariat; Hong-Ying Huang; Rey-Chen Pong; Raheela Ashfaq; Ellen Shapiro; Yair Lotan; Arthur I Sagalowsky; Xue-Ru Wu; Jer-Tsong Hsieh
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4400-6.
2007: Joshua M Stern; Robert S Svatek; Sangtae Park; Michael Hermann; Yair Lotan; Arthur I Sagalowsky; Jeffrey A Cadeddu
Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
BJU international 2007;100(2):287-90.
2007: Terry L Deibel; Benjamin D Sommers; Richard Gilmore; Arthur I Sagalowsky; Neal Shore
Talking to patients about risk.
Urologic oncology 2007;25(4):348-50.
2007: Bahaa S Malaeb; Hani H Rashid; Yair Lotan; Seyyed M Khoddami; Shahrokh F Shariat; Arthur I Sagalowsky; John D McConnell; Claus G Roehrborn; Kenneth S Koeneman
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Urologic oncology 2007;25(4):291-7.
2007: Jose A Karam; Jinhai Fan; Jennifer Stanfield; Edmond Richer; Elie A Benaim; Eugene P Frenkel; Peter P Antich; Arthur I Sagalowsky; Ralph P Mason; Jer-Tsong Hsieh
The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.
International journal of cancer. Journal international du cancer 2007;120(8):1795-802.
2007: Shahrokh F Shariat; Alexandre R Zlotta; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(4):445-59.
2007: Shahrokh F Shariat; Raheela Ashfaq; Pierre I Karakiewicz; Osamah Saeedi; Arthur I Sagalowsky; Yair Lotan
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Cancer 2007;109(6):1106-13.
2007: Vitaly Margulis; Shahrokh F Shariat; Raheela Ashfaq; Melissa Thompson; Arthur I Sagalowsky; Jer-Tsong Hsieh; Yair Lotan
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
The Journal of urology 2007;177(3):1163-8.
2007: Matthew Nielsen; Shahrokh F Shariat; Pierre I Karakiewicz; Yair Lotan; Craig G Rogers; Gilad E Amiel; Patrick J Bastian; Amnon Vazina; Amit Gupta; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ganesh S Palapattu
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
European urology 2007;51(3):699-706; discussion 706-8.
2007: Jose A Karam; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Arthur I Sagalowsky; Claus G Roehrborn; Shahrokh F Shariat
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
The lancet oncology 2007;8(2):128-36.
2007: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
The Journal of urology 2007;177(2):481-7; discussion 487.
2007: Richard E Hautmann; Hassan Abol-Enein; Khaled S Hafez; Isao Haro; Wiking Mansson; Robert D Mills; James E Montie; Arthur I Sagalowsky; John P Stein; Arnulf Stenzl; Urs E Studer; Bjoern G Volkmer
Urinary diversion.
Urology 2007;69(1 Suppl):17-49.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
European urology 2007;51(1):152-60.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
European urology 2007;51(1):137-49; discussion 149-51.
2006: Vitaly Margulis; Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7369-73.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
The Journal of urology 2006;176(6 Pt 1):2414-22; discussion 2422.
2006: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
Human pathology 2006;37(12):1568-76.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Gilad E Amiel; Yair Lotan; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Amit Gupta; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6663-76.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Robert S Svatek; Yair Lotan; Michael P Herman; Michael Hermann; David A Duchene; Arthur I Sagalowsky; Jeffrey A Cadeddu
The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
The Journal of urology 2006;176(4 Pt 1):1321-5; discussion 125.
2006: Khaled F Abdel-Aziz; J Kyle Anderson; Robert S Svatek; Vitaly Margulis; Arthur I Sagalowsky; Jeffrey A Cadeddu
Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
Journal of endourology / Endourological Society 2006;20(9):627-31.
2006: Shahrokh F Shariat; Ganesh S Palapattu; Gilad E Amiel; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
Urology 2006;68(3):538-42.
2006: Rey-Chen Pong; Ryan Roark; Jiun-Yih Ou; Jianhai Fan; Jennifer Stanfield; Eugene P Frenkel; Arthur I Sagalowsky; Jer-Tsong Hsieh
Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
Cancer research 2006;66(17):8822-8.
2006: Shahrokh F Shariat; Michael Marberger; Yair Lotan; Marta Sanchez-Carbayo; Craig D Zippe; Gerson Lüdecke; Hans Boman; Ihor S Sawczuk; Martin G Friedrich; Roberto Casella; Christine Mian; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Rupesh Raina; Naoto Miyanaga; Arthur I Sagalowsky; Claus G Roehrborn; Pierre I Karakiewicz
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Yair Lotan; Robert S Svatek; Arthur I Sagalowsky
Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.
Cancer 2006;107(5):982-90.
2006: Jennifer B Sherwood; Arthur I Sagalowsky
The diagnosis and treatment of urethral recurrence after radical cystectomy.
Urologic oncology 2006;24(4):356-61.
2006: Robert S Svatek; Arthur I Sagalowsky; Yair Lotan
Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.
Urologic oncology 2006;24(4):338-43.
2006: Jordon G Lubahn; Arthur I Sagalowsky; David H Rosenbaum; Erkan Dikmen; Rehal A Bhojani; Michelle C Paul; Bart L Dolmatch; Shellie C Josephs; Elie A Benaim; Barry S Levinson; Michael A Wait; W Steves Ring; J Michael DiMaio
Contemporary techniques and safety of cardiovascular procedures in the surgical management of renal cell carcinoma with tumor thrombus.
The Journal of thoracic and cardiovascular surgery 2006;131(6):1289-95.
2006: Craig G Rogers; Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Yair Lotan; Amit Gupta; Amnon Vazina; Amiel Gilad; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(6):2048-53; discussion 2053.
2006: Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Yair Lotan; Amnon Vazina; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
The Journal of urology 2006;175(5):1645-9; discussion 1649.
2006: Pierre I Karakiewicz; Serge Benayoun; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Michael Marberger; Shahrokh F Shariat
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: Robert S Svatek; Michael P Herman; Yair Lotan; Roberto Casella; Jer-Tsong Hsieh; Arthur I Sagalowsky; Shahrokh F Shariat
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
Cancer 2006;106(8):1701-7.
2006: David A Duchene; D Brooke Johnson; Lucas Jacomides; Kenneth Ogan; Arthur I Sagalowsky; Jeffrey A Cadeddu
Effect of multisite radiofrequency ablation on porcine renal function.
Journal of endourology / Endourological Society 2006;20(4):278-80.
2006: Zhengwang Zhang; Jose A Karam; Eugene P Frenkel; Arthur I Sagalowsky; Jer-Tsong Hsieh
The application of epigenetic modifiers on the treatment of prostate and bladder cancer.
Urologic oncology 2006;24(2):152-60.
2005: Michael F Sarosdy; Catherine M Tangen; Geoffrey R Weiss; Blake R Nestok; Mitchell C Benson; Paul F Schellhammer; Arthur I Sagalowsky; David P Wood Jr; E David Crawford
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.
Urologic oncology 2005;23(6):386-9.
2005: Yair Lotan; Amit Gupta; Shahrokh F Shariat; Ganesh S Palapattu; Amnon Vazina; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Paul Perotte; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6533-9.
2005: Edward D Matsumoto; D Brooke Johnson; Kenneth Ogan; Clayton Trimmer; Arthur I Sagalowsky; Vitaly Margulis; Jeffrey A Cadeddu
Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
Urology 2005;65(5):877-81.
2005: Shahrokh F Shariat; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Ihor S Sawczuk; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Frank H Wians; Claus G Roehrborn; Yair Lotan; Paul Perrotte; Serge Benayoun; Michael Marberger; Pierre I Karakiewicz
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2004: Vitaly Margulis; Edward D Matsumoto; Guy Lindberg; Lutfi Tunc; Grant Taylor; Arthur I Sagalowsky; Jeffrey A Cadeddu
Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation.
Urology 2004;64(4):660-3.
2004: Seyed M Khoddami; Shahrokh F Shariat; Yair Lotan; Hossein Saboorian; John D McConnell; Arthur I Sagalowsky; Claus G Roehrborn; Kenneth S Koeneman
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
BJU international 2004;94(1):42-6.
2004: Yair Lotan; Shahrokh F Shariat; Seyed M Khoddami; Hossein Saboorian; Kenneth S Koeneman; Jeffrey A Cadeddu; Arthur I Sagalowsky; John D McConnell; Claus G Roehrborn
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.
The Journal of urology 2004;171(6 Pt 1):2209-14.
2004: Yair Lotan; David A Duchene; Jeffrey A Cadeddu; Arthur I Sagalowsky; Kenneth S Koeneman
Changing management of organ-confined renal masses.
Journal of endourology / Endourological Society 2004;18(3):263-8.
2004: Shahrokh F Shariat; Roberto Casella; Frank H Wians; Raheela Ashfaq; Jody Balko; Tullio Sulser; Thomas C Gasser; Arthur I Sagalowsky
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
European urology 2004;45(3):304-13; author reply 313.
2004: Shahrokh F Shariat; Seyed M Khoddami; Hossein Saboorian; Kenneth S Koeneman; Arthur I Sagalowsky; Jeffrey A Cadeddu; John D McConnell; Marisa N Holmes; Claus G Roehrborn
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
The Journal of urology 2004;171(3):1122-7.
2004: Ubaradka G Sathyanarayana; Riichiroh Maruyama; Asha Padar; Makoto Suzuki; Jolanta Bondaruk; Arthur I Sagalowsky; John D Minna; Eugene P Frenkel; H Barton Grossman; Bogdan Czerniak; Adi F Gazdar
Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes.
Cancer research 2004;64(4):1425-30.
2003: Rey-Chen Pong; Yun-Ju Lai; Hong Chen; Takatsugu Okegawa; Eugene P Frenkel; Arthur I Sagalowsky; Jer-Tsong Hsieh
Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells.
Cancer research 2003;63(24):8680-6.
2003: James M Elmore; Keith T Kadesky; Kenneth S Koeneman; Arthur I Sagalowsky
Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Cancer 2003;98(11):2329-34.
2003: D Brooke Johnson; Grant D Taylor; Yair Lotan; Arthur I Sagalowsky; Kenneth S Koenemann; Jeffrey A Cadeddu
The effects of radio frequency ablation on renal function and blood pressure.
The Journal of urology 2003;170(6 Pt 1):2234-6.
2003: David A Duchene; Yair Lotan; Jeffrey A Cadeddu; Arthur I Sagalowsky; Kenneth S Koeneman
Histopathology of surgically managed renal tumors: analysis of a contemporary series.
Urology 2003;62(5):827-30.
2003: David A Duchene; D Brooke Johnson; Shujun Li; Jay S Roden; Arthur I Sagalowsky; Jeffrey A Cadeddu
Laparoscopic donor nephrectomy at a low volume living donor transplant center: successful outcomes can be expected.
The Journal of urology 2003;170(3):731-3.
2002: Arthur I Sagalowsky
The 1997 TNM classification of renal cell carcinoma revisited: the pendulum swings back.
Current opinion in urology 2002;12(5):371-3.
2002: Tanja Fehm; Arthur I Sagalowsky; Edward Clifford; Peter D Beitsch; Hossein Saboorian; David M Euhus; Songdong Meng; Larry Morrison; Thomas Tucker; Nancy Lane; B Michael Ghadimi; Kerstin Heselmeyer-Haddad; Thomas Ried; Chandra Rao; Jonathan Uhr
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2073-84.
2002: Kenneth Ogan; Jeffrey A Cadeddu; Arthur I Sagalowsky
Radio frequency ablation induced acute renal failure.
The Journal of urology 2002;168(1):186.
2002: Arthur I Sagalowsky; Eugene P Frenkel
Cobalamin profiles in patients after urinary diversion.
The Journal of urology 2002;167(4):1696-700.
2002: Alfredo Velasco; Stephen M Hewitt; Paul S Albert; M Hossein; Helmar Rosenberg; Carlos Martinez; Arthur I Sagalowsky; John D McConnell; W Marston; Fredrick S Leach
Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
Cancer 2002;94(3):690-9.
2002: Arthur I Sagalowsky
Re: sensory disturbance of the thigh after renal transplantation. Y. Murata, K. Sakamoto, R. Hayashi, K. Takahashi, S.-I. Nakamura and H. Moriya. J Urol, 165: 770-772, 2001.
The Journal of urology 2002;167(1):259.
2001: Riichiroh Maruyama; Shinichi Toyooka; Kiyomi O Toyooka; Kenichi Harada; Arvind K Virmani; Sabine Zöchbauer-Müller; Alfredo J Farinas; Funda Vakar-Lopez; John D Minna; Arthur I Sagalowsky; Bogdan Czerniak; Adi F Gazdar
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
Cancer research 2001;61(24):8659-63.
2001: Takatsugu Okegawa; Rey-Chen Pong; Yingming Li; JM Bergelson; Arthur I Sagalowsky; Jer-Tsong Hsieh
The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.
Cancer research 2001;61(17):6592-600.
2001: Anirban Maitra; Asha Rathi; Adi F Gazdar; Arthur I Sagalowsky; Raheela Ashfaq
Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.
Cancer 2001;93(1):73-9.
2000: Fredrick S Leach; Alfredo Velasco; Jer-Tsong Hsieh; Arthur I Sagalowsky; John D McConnell
The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
The Journal of urology 2000;164(5):1830-3.
2000: DS Blander; Philippe E Zimmern; Gary E Lemack; Arthur I Sagalowsky
Transvaginal repair of postcystectomy peritoneovaginal fistulae.
Urology 2000;56(2):320-1.
2000: Fredrick S Leach; Jer-Tsong Hsieh; Kyle H Molberg; M Hossein Saboorian; John D McConnell; Arthur I Sagalowsky
Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Cancer 2000;88(10):2333-41.
2000: MC Hall; Yingming Li; Rey-Chen Pong; BD Ely; Arthur I Sagalowsky; Jer-Tsong Hsieh
The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.
The Journal of urology 2000;163(3):1033-8.
1999: Arthur I Sagalowsky; Kyle H Molberg
Solitary metastasis of renal cell carcinoma to the contralateral adrenal gland 22 years after nephrectomy.
Urology 1999;54(1):162.
1999: MC Hall; R J Fritzsch; Arthur I Sagalowsky; A Ahrens; B Petty; Claus G Roehrborn
Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
Urology 1999;53(5):898-902; discussion 902-3.
1999: Yingming Li; Rey-Chen Pong; JM Bergelson; MC Hall; Arthur I Sagalowsky; Ching-Ping Tseng; Z w Wang; Jer-Tsong Hsieh
Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.
Cancer research 1999;59(2):325-30.
1998: MC Hall; S Womack; Arthur I Sagalowsky; T Carmody; M D Erickstad; Claus G Roehrborn
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.
Urology 1998;52(4):594-601.
1998: MC Hall; J S Womack; Claus G Roehrborn; T Carmody; Arthur I Sagalowsky
Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy.
The Journal of urology 1998;160(3 Pt 1):703-6.
1998: Arthur I Sagalowsky
Further experience with split-cuff nipple ureteral reimplantation in urinary diversion.
The Journal of urology 1998;159(6):1843-4.
1998: Michael F Sarosdy; M J Manyak; Arthur I Sagalowsky; A Belldegrun; M C Benson; W Bihrle; P R Carroll; William J Ellis; M A Hudson; Francis E Sharkey
Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin.
Urology 1998;51(2):226-31.
1997: Elizabeth Louise Wiley; P Davidson; D D McIntire; Arthur I Sagalowsky
Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia.
Urology 1997;49(5):692-6.
1996: Claus G Roehrborn; A Gregory; John D McConnell; Arthur I Sagalowsky; Frank H Wians
Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
Urology 1996;48(6A Suppl):23-32.
1995: Arthur I Sagalowsky
Early results with split-cuff nipple ureteral reimplants in urinary diversion.
The Journal of urology 1995;154(6):2028-31.
1995: Biff F Palmer; Arthur I Sagalowsky; D A McQuitty; I Dawidson; Miguel A Vazquez; Christopher Y Lu
Lymphoproliferative disease presenting as obstructive uropathy after renal transplantation.
The Journal of urology 1995;153(2):392-4.
1994: Robin H Amirkhan; Kyle H Molberg; Elizabeth Louise Wiley; P Nurenberg; Arthur I Sagalowsky
Primary leiomyosarcoma of the seminal vesicle.
Urology 1994;44(1):132-5.
1994: Arthur I Sagalowsky; K T Kadesky; D M Ewalt; T J Kennedy
Factors influencing adrenal metastasis in renal cell carcinoma.
The Journal of urology 1994;151(5):1181-4.
1993: I Dawidson; M Exley; S Remmich; Arthur I Sagalowsky; M Serbin; T Peterson; P Peters
Increasing organ donation at a large inner city public hospital.
Transplantation proceedings 1993;25(6):3139.
1993: Michael L Cher; Sara Milchgrub; Arthur I Sagalowsky
Transitional cell carcinoma of the ureteral stump 23 years after radical nephrectomy for adenocarcinoma.
The Journal of urology 1993;149(1):106-8.
1992: I J Dawidson; Z F Sandor; L Coorpender; B Palmer; P Peters; C Lu; Arthur I Sagalowsky; R Risser; C Willms
Intraoperative albumin administration affects the outcome of cadaver renal transplantation.
Transplantation 1992;53(4):774-82.
1992: W T Wilson; E Frenkel; F Vuitch; Arthur I Sagalowsky
Testicular tumors in men with human immunodeficiency virus.
The Journal of urology 1992;147(4):1038-40.
1992: I Dawidson; C Lu; B Palmer; P Peters; P Rooth; R Risser; Arthur I Sagalowsky; Z Sandor
Verapamil (VP) improves the outcome after renal transplantation (CRT).
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S60-2.
1991: I Dawidson; P Rooth; C Lu; Arthur I Sagalowsky; K Diller; B Palmer; P Peters; R Risser; Z Sandor; F Seney
Verapamil improves the outcome after cadaver renal transplantation.
Journal of the American Society of Nephrology : JASN 1991;2(5):983-90.
1991: Biff F Palmer; I Dawidson; Arthur I Sagalowsky; Z Sandor; Christopher Y Lu
Improved outcome of cadaveric renal transplantation due to calcium channel blockers.
Transplantation 1991;52(4):640-5.
1991: Claus G Roehrborn; Arthur I Sagalowsky; P C Peters
Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder.
The Journal of urology 1991;146(1):36-9.
1991: Arthur I Sagalowsky
Simplified method for outpatient teaching of continent reservoir catheterization.
Urology 1991;37(2):167.
1991: José R Moraes; Maria Moraes; Y Luo; P C Peters; Arthur I Sagalowsky; I Dawidson; C Lu; Peter Stastny
Crossmatch with donor skin: characterization of alloantibodies and correlation with early kidney rejection.
Transplantation proceedings 1991;23(1 Pt 1):471-2.
1990: I Dawidson; P Rooth; C Alway; T Dulzo; B Palmer; C Lu; P Peters; Arthur I Sagalowsky; Z Sandor
Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity.
Transplantation proceedings 1990;22(4):1379-80.
1990: Arthur I Sagalowsky; David H Ewalt; Kyle H Molberg; P C Peters
Predictors of residual mass histology after chemotherapy for advanced testis cancer.
Urology 1990;35(6):537-42.
1990: I J Dawidson; L Coorpender; D Fisher; H Helderman; A Hull; B Palmer; P Peters; Arthur I Sagalowsky; Z F Sandor; Robert D Toto
Impact of race on renal transplant outcome.
Transplantation 1990;49(1):63-7.
1989: Biff F Palmer; J Hernandez; Arthur I Sagalowsky; I Dawidson; J Harold Helderman
Documentation of fungal pyelonephritis of the renal allograft by fine needle aspiration cytology.
Transplantation proceedings 1989;21(4):3598-9.
1988: J A Hernandez; J Glennie; Robert D Toto; Arthur I Sagalowsky; I Dawidson; J Harold Helderman
A novel use of fine-needle aspiration biopsy: documentation of acute pyelonephritis of the transplanted kidney.
Transplantation proceedings 1988;20(4):632-4.
1988: Arthur I Sagalowsky; M E Reisman; I Dawidson; Robert D Toto; P C Peters; J Harold Helderman
Late cyclosporine conversion carries risk of irreversible rejection.
Transplantation proceedings 1988;20(3 Suppl 3):157-60.
1988: J R Embrey; F G Silva; J Harold Helderman; P C Peters; Arthur I Sagalowsky
Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy.
The Journal of urology 1988;139(3):580-1.
1987: C G Roehrborn; C M Teigland; Arthur I Sagalowsky
Functional characteristics of the Camey ileal bladder.
The Journal of urology 1987;138(4):739-42.
1987: I Dawidson; L Coorpender; D Drake; H Helderman; A Hull; P Peters; Arthur I Sagalowsky; J Reisch
Intraoperative albumin improves the outcome of cadaver renal transplantation.
Transplantation proceedings 1987;19(5):4137-9.
1987: I Dawidson; P Peters; Arthur I Sagalowsky; D Abshier; L Coorpender
The effect of intraoperative fluid management on the incidence of acute tubular necrosis.
Transplantation proceedings 1987;19(1 Pt 3):2056-7.
1984: C R Saxton; P Gailiunas; J Harold Helderman; R A Farkas; R McCoy; J Diehl; Arthur I Sagalowsky; F K Murphy; E D Ross; F R Silva
Progressive multifocal leukoencephalopathy in a renal transplant recipient. Increased diagnostic sensitivity of computed tomographic scanning by double-dose contrast with delayed films.
The American journal of medicine 1984;77(2):333-7.
1984: John D McConnell; Arthur I Sagalowsky; S E Lewis; P Gailiunas; J Harold Helderman; I Dawidson; P C Peters
Prospective evaluation of renal allograft dysfunction with 99mtechnetium-diethylenetriaminepentaacetic acid renal scans.
The Journal of urology 1984;131(5):875-9.
1983: Arthur I Sagalowsky; C W Ransler; P C Peters; R M Dickerman; P Gailiunas; J Harold Helderman; A R Hull; C Atkins
Urologic complications in 505 renal transplants with early catheter removal.
The Journal of urology 1983;129(5):929-32.
1983: Arthur I Sagalowsky; P Gailiunas; J Harold Helderman; A R Hull; R M Dickerman; C W Ransler; C Atkins; P C Peters
Renal transplantation in diabetic patients: the end result does justify the means.
The Journal of urology 1983;129(2):253-5.
1982: Arthur I Sagalowsky; H Milam; L R Reveley; F G Silva
Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer.
The Journal of urology 1982;128(5):951-2.